150 related articles for article (PubMed ID: 33035545)
21. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats.
Ansari MJ; Anwer MK; Jamil S; Al-Shdefat R; Ali BE; Ahmad MM; Ansari MN
Drug Deliv; 2016 Jul; 23(6):1972-9. PubMed ID: 26017100
[TBL] [Abstract][Full Text] [Related]
22. Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy.
Rodenak-Kladniew B; Islan GA; de Bravo MG; Durán N; Castro GR
Colloids Surf B Biointerfaces; 2017 Jun; 154():123-132. PubMed ID: 28334689
[TBL] [Abstract][Full Text] [Related]
23. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
[TBL] [Abstract][Full Text] [Related]
24. Catanionic Hybrid Lipid Nanovesicles for Improved Bioavailability and Efficacy of Chemotherapeutic Drugs.
Xie X; He D; Wu Y; Wang T; Zhong C; Zhang J
Methods Mol Biol; 2021; 2211():57-68. PubMed ID: 33336270
[TBL] [Abstract][Full Text] [Related]
25. Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel.
Gou J; Feng S; Liang Y; Fang G; Zhang H; Yin T; Zhang Y; He H; Wang Y; Tang X
Mol Pharm; 2017 Nov; 14(11):3750-3761. PubMed ID: 28945434
[TBL] [Abstract][Full Text] [Related]
26. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
27. Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies.
Bondì ML; Craparo EF; Giammona G; Cervello M; Azzolina A; Diana P; Martorana A; Cirrincione G
Drug Deliv; 2007 Feb; 14(2):61-7. PubMed ID: 17364869
[TBL] [Abstract][Full Text] [Related]
28. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
29. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
30. The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.
Sadeghzadeh H; Pilehvar-Soltanahmadi Y; Akbarzadeh A; Dariushnejad H; Sanjarian F; Zarghami N
Anticancer Agents Med Chem; 2017; 17(10):1363-1373. PubMed ID: 28270067
[TBL] [Abstract][Full Text] [Related]
31. In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles.
Garg A; Bhalala K; Tomar DS; Wahajuddin
Int J Pharm; 2017 Jan; 516(1-2):120-130. PubMed ID: 27989820
[TBL] [Abstract][Full Text] [Related]
32. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
33. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
34. Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles.
Gumireddy A; Christman R; Kumari D; Tiwari A; North EJ; Chauhan H
AAPS PharmSciTech; 2019 Mar; 20(4):145. PubMed ID: 30887133
[TBL] [Abstract][Full Text] [Related]
35. Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery.
Feng H; Zhu Y; Fu Z; Li D
Chem Biol Drug Des; 2017 Nov; 90(5):867-872. PubMed ID: 28432812
[TBL] [Abstract][Full Text] [Related]
36. Preparation and optimization of poly (lactic acid) nanoparticles loaded with fisetin to improve anti-cancer therapy.
Feng C; Yuan X; Chu K; Zhang H; Ji W; Rui M
Int J Biol Macromol; 2019 Mar; 125():700-710. PubMed ID: 30521927
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical Characterization of Curcumin Loaded Chitosan Nanoparticles: Implications in Cervical Cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MMA
Anticancer Agents Med Chem; 2018; 18(8):1131-1137. PubMed ID: 29651963
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
39. Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material.
Li W; Zhang T; Ye Y; Zhang X; Wu B
Int J Pharm; 2015 Nov; 495(2):948-55. PubMed ID: 26453780
[TBL] [Abstract][Full Text] [Related]
40. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
